These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era. La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230 [TBL] [Abstract][Full Text] [Related]
4. Facial lymphoedema as an indicator of terminal disease in oral HIV-associated Kaposi sarcoma. Feller L; Khammissa RA; Wood NH; Jose RJ; Lemmer J SADJ; 2010 Feb; 65(1):14, 16-8. PubMed ID: 20411797 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. Feller L; Anagnostopoulos C; Wood NH; Bouckaert M; Raubenheimer EJ; Lemmer J J Periodontol; 2008 Feb; 79(2):362-8. PubMed ID: 18251652 [TBL] [Abstract][Full Text] [Related]
6. Gingival involvement in a case series of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Kalpidis CD; Lysitsa SN; Lombardi T; Kolokotronis AE; Antoniades DZ; Samson J J Periodontol; 2006 Mar; 77(3):523-33. PubMed ID: 16512768 [TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma in sub-Saharan Africa: a current perspective. Mosam A; Aboobaker J; Shaik F Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745 [TBL] [Abstract][Full Text] [Related]
8. Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma? Dalla Pria A; Hayward K; Bower M Expert Rev Anticancer Ther; 2013 Feb; 13(2):203-9. PubMed ID: 23406561 [TBL] [Abstract][Full Text] [Related]
9. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals. Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020 [TBL] [Abstract][Full Text] [Related]
10. New drug targets in Kaposi sarcoma. Sullivan RJ; Pantanowitz L Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836 [TBL] [Abstract][Full Text] [Related]
20. Histological features of kaposi sarcoma in a patient receiving highly active antiviral therapy. Eng W; Cockerell CJ Am J Dermatopathol; 2004 Apr; 26(2):127-32. PubMed ID: 15024195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]